High Tide Inc.
HITTF
Other OTC0.15
USD
+0.00
- -
High Tide Inc.
HITTF
(Other OTC)
Recent
price
0.15
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- High Tide Inc. High Tide Inc. (Nasdaq: HITI; TSXV: HITI) operates as a vertically integrated cannabis retailer focused on bricks-and-mortar stores, e-commerce platforms, wholesale distribution, and related technology services in Canada, the United States, Europe, and select international markets. Founded in 2009 and headquartered in Calgary, Alberta, the company manages Canada's largest cannabis retail chain under the Canna Cabana brand, encompassing over 180 licensed stores across Alberta, Ontario, Saskatchewan, British Columbia, and Manitoba; offers proprietary retail technology via the Fastendr automated kiosk system for streamlined transactions and data analytics; and sells consumption accessories, hemp-derived CBD products, and cannabis lifestyle items through global e-commerce sites including Grasscity.com, SmokeCartel.com, DailyHighClub.com, DankStop.com, FABCBD.com, NuleafNaturals.com, and Blessed CBD; while providing wholesale distribution through Valiant and licensing via Famous Brandz, alongside proprietary brands such as Queen of Bud, Cabana Cannabis Co., Vodka Glass, Puff Puff Pass, Dopezilla, Atomik, and Hue. High Tide generates revenue primarily from its retail and wholesale segments, targeting recreational cannabis consumers, frequent buyers via the Cabana Club discount membership program with over 1.3 million members, and third-party retailers seeking operational efficiency and consumer insights. In recent developments, High Tide closed a $30 million convertible debt financing from a subsidiary of Cronos Group Inc. Cronos Group Inc. in July 2025 to support acquisitions and organic expansion toward exceeding 300 Canadian stores; acquired a 51% majority stake in Germany's Remexian Pharma GmbH in 2025 for approximately €27.2 million, marking entry into the European medical cannabis market with an option for full ownership and adding significant annualized revenue and EBITDA; and continues aggressive store openings, including new Canna Cabana locations in Toronto and Winnipeg announced in June 2025.